Diabetes Mellitus, Type 2: all 9,589 studies
Page 87 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762112Phase 3
- Signaling Mechanisms and Vascular Function in Diabetes MellitusCompletedNCT00761852Phase 2/3
- Genetic Variants and Phenotypic Characteristics of Patients With T2DMStatus unknownNCT00760292
- Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.TerminatedNCT00759720Phase 3
- The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic PatientsStatus unknownNCT00758927Phase 4
- Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 MonthsCompletedNCT00755833
- A Study of the Effects of Exercise Intensity on Insulin Sensitivity in Overweight YouthCompletedNCT00755547Phase 4
- A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.CompletedNCT00755287Phase 3
- A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.CompletedNCT00754988Phase 3
- Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 DiabetesWithdrawnNCT00754689Phase 3
- Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic NephropathyCompletedNCT00754143Phase 1
- Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 DiabetesCompletedNCT00753181Phase 3
- How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?Status unknownNCT00749047Phase 4
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PETCompletedNCT00747968Phase 2/3
- Insulin Effects on Metabolism and Cardiovascular Function in Type 2 DiabetesStatus unknownNCT00747409Phase 4
- How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.CompletedNCT00747383Not applicable
- A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 DiabetesCompletedNCT00747175Phase 1
- Switch From Metformin Monotherapy to a Bitherapy With Metformin and RepaglinideCompletedNCT00745433
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.CompletedNCT00744926Phase 3
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.CompletedNCT00744367Phase 3
- A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or ThiazolidinedioneCompletedNCT00743002Phase 2
- Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic PatientsCompletedNCT00742976Phase 4
- Type 2 Diabetes Mellitus: New Approaches to Optimize Medical Care in General PracticeCompletedNCT00742547Not applicable
- Observational Study on Safety of Self-titration of Once Daily Levemir®CompletedNCT00740519
- An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 DiabetesCompletedNCT00738153
- Variation in Sulphonylurea Response in Type 2 DiabetesTerminatedNCT00738088Phase 4
- Randomized Crossover Study of Magnesium SupplementationCompletedNCT00737815Not applicable
- Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of DiabetesCompletedNCT00737776
- Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With PioglitazoneCompletedNCT00737347Phase 3
- Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes MellitusStatus unknownNCT00737152Phase 2
- Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 DiabetesCompletedNCT00736515Phase 4
- Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 DiabetesCompletedNCT00735501
- Risk of Hypoglycemia in Type 2 DiabetesCompletedNCT00734669
- A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing.CompletedNCT00733577Phase 1
- Metabolic Adaptation to DiabetesCompletedNCT00732862Not applicable
- Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DMWithdrawnNCT00732147Not applicable
- Bone Turnover in Type 2 Diabetes PatientsStatus unknownNCT00732121Phase 4
- Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 DiabetesCompletedNCT00729898
- A Trial of Two Diets for Weight and Diabetes ManagementCompletedNCT00729196Not applicable
- Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 DiabetesStatus unknownNCT00728403Phase 2
- Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)CompletedNCT00728351Phase 3
- Assessment of Thrombogenicity in Acute Coronary SyndromeCompletedNCT00728286
- Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)CompletedNCT00728156Phase 4
- "Information Technology Methodology for Patient Motivation in Diabetes Management."CompletedNCT00727896Phase 1
- Basal Insulin for Type 2 Diabetes Patients Treated in Outpatient Clalit ClinicsCompletedNCT00726674
- Dietary Control of Type 2 Diabetes: Low-Carbohydrate Mediterranean Diet Versus Low-Fat DietCompletedNCT00725257Not applicable
- Chronotherapy with Low-dose Aspirin for Primary PreventionActive, not recruitingNCT00725127Phase 4
- Sleep Loss and Energy Metabolism in People With Family History of Type 2 Diabetes.CompletedNCT00724087Not applicable
- REACH-OUT: Chicago Children's Diabetes Prevention ProgramCompletedNCT00723853Not applicable
- Anti-Inflammatory Effects of PioglitazoneCompletedNCT00722631Not applicable
- TODAY Genetics StudyCompletedNCT00722397
- Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring SystemCompletedNCT00722241
- Fitness and Sleep in People With Family History of Type 2 Diabetes.CompletedNCT00721084
- Sleep Loss and Glucose Metabolism in People With Family History of Type 2 Diabetes.CompletedNCT00721019Not applicable
- Glucose Metabolism and Sleep in People With Family History of Type 2 Diabetes.CompletedNCT00720889
- A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.CompletedNCT00717457Phase 3
- A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric DiabetesCompletedNCT00717223
- Lifestyle Intervention's Impact on Health Care CostsCompletedNCT00717158Not applicable
- GIP, GLP-1 and GLP-2 in Type 2 Diabetic HyperglucagonemiaCompletedNCT00716170
- Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic AgentsCompletedNCT00715780
- Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 DiabetesCompletedNCT00715663
- Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of DiabetesCompletedNCT00715351
- Insulin Detemir and Waist CircumferenceCompletedNCT00714844
- Reducing Distress and Improving Self-Care in DiabetesCompletedNCT00714441Not applicable
- Incretin Physiology Associated With Steroid Hormone TreatmentCompletedNCT00713440Not applicable
- Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 DiabetesCompletedNCT00712478
- Community Health Worker Reduces Care UtilizationCompletedNCT00711152Phase 4
- Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic HumansCompletedNCT00710008Not applicable
- Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 DiabetesCompletedNCT00709917
- Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®CompletedNCT00709683
- Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes MellitusCompletedNCT00709475
- Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)CompletedNCT00708578Phase 4
- The Influence of Fatty-Acids on Systemic and Subcutaneous CytokinesCompletedNCT00708266Not applicable
- Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)TerminatedNCT00707590Phase 1
- The Effect of a Traditional Dietary Intervention on Diabetes Mellitus and Cardiovascular Disease Risk Factors in a First Nation Community: A Pilot StudyCompletedNCT00707460Phase 1
- Observational Study to Evaluate the Safety of Levemir® in DiabetesCompletedNCT00706017
- Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.CompletedNCT00705952Not applicable
- Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 DiabetesCompletedNCT00704574
- Improvement of Insulin Resistance With Traditional Chinese Treatment in Patients With Type 2 DiabetesCompletedNCT00704236Phase 4
- Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 DiabetesCompletedNCT00704223
- Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Type 2 DiabeticsStatus unknownNCT00703612Phase 1/2
- A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 DiabetesCompletedNCT00703482Phase 2
- Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot StudyCompletedNCT00703417
- Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic ControlCompletedNCT00701831Phase 4
- Observational Study to Evaluate the Safety While Using Levemir®CompletedNCT00701155
- Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose ControlCompletedNCT00700960
- Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 DiabetesCompletedNCT00700908Not applicable
- Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention TrialStatus unknownNCT00700856Phase 4
- Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 DiabetesCompletedNCT00700830
- Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 DiabetesCompletedNCT00700765
- An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised SubjectsCompletedNCT00700648
- The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 DiabetesCompletedNCT00699426Phase 3
- Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 DiabetesCompletedNCT00699179
- Ezetimibe and Statins on Postprandial Lipemia in Type 2 DiabetesCompletedNCT00699023Phase 4
- Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 DiabetesCompletedNCT00698802Phase 2
- Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 DiabetesTerminatedNCT00698789Phase 2
- An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic TreatmentCompletedNCT00698269
- Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 DiabetesCompletedNCT00698126
- Strength and Nutrition Outcomes for Latino AdolescentsCompletedNCT00697580Not applicable
- Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 DiabeticsCompletedNCT00697450